The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF study

Recent randomized trials have consistently demonstrated the marked efficacy of warfarin in reducing the risk of stroke caused by nonrheumatic atrial fibrillation. These trials have provided conflicting evidence on the effect of aspirin. We report the aspirin analysis from the BAATAF study, a trial i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 1992-12, Vol.124 (6), p.1567-1573
Hauptverfasser:	Singer, Daniel E., Hughes, Robert A., Gress, Daryl R., Sheehan, Mary A., Oertel, Lynn B., Maraventano, Sue Ward, Blewett, Dyan Ryan, Rosner, Bernard, Kistler, J. Philip, BAATAF Investigators
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Aspirin - therapeutic use Atrial Fibrillation - complications Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Cerebrovascular Disorders - epidemiology Cerebrovascular Disorders - etiology Cerebrovascular Disorders - prevention & control Female Humans Male Medical sciences Middle Aged Pharmacology. Drug treatments Risk Factors Treatment Outcome Warfarin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!